Sotera Health Company (SHC)

NMS – Real vaqt narxi. Valyuta: USD

17.38

+0.28 (1.64%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

17.47

+0.09 (0.52%)

Bozordan keyin: Jun 26, 2026, 5:26 PM EDT

08.06.2026

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

03.06.2026

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

19.05.2026

Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

11.05.2026

Sotera Health Announces Secondary Offering of Common Stock

CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0.01 per share. All 31,838,253 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders.

05.05.2026

Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript

05.05.2026

Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

05.05.2026

Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates

Sotera Health Company (SHC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.14 per share a year ago.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
SHC	Goldman	Buy	undefined >> $20	June 5th 2026

Press-relizlar

11.05.2026

Sotera Health Announces Secondary Offering of Common Stock

05.05.2026

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Q1 2026 net revenues increased 10.0%, or 6.5% on a co nstant currenc y basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 Q1 2026 Adjusted EBITDA ( 1 ) increased 10.5%, or 6.9% on a constant currency basis Q1 2026 Adjusted EPS (1) of $0.18 , an increase of 29% per diluted share Company reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, both on a constant currency basis Company announced planned CEO transition in a separate release today CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2026. “We delivered a strong start to the year, with solid revenue and Adjusted EBITDA growth while driving margin expansion,” said Chairman and Chief Executive Officer, Michael B.

05.05.2026

Sotera Health Announces Leadership Transition

Alton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Directors CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced the appointment of Alton Shader to the role of Chief Executive Officer (“CEO”) of the Company, effective May 26, 2026, as part of a planned leadership transition.

16.03.2026

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

CLEVELAND, March 16, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company” or “Sotera Health”), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today that it has appointed Kenneth D. Krause as a new independent director to its Board of Directors (the “Board”).

Sotera Health Company (SHC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Sotera Health Company (SHC)

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript

Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Sotera Health Announces Leadership Transition

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript

Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Sotera Health Announces Leadership Transition

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

Search stocks

Sotera Health Company (SHC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Sotera Health Company (SHC)

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript

Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Sotera Health Announces Leadership Transition

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript

Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook

Sotera Health Announces Leadership Transition

Sotera Health Appoints Kenneth D. Krause to the Board of Directors